We investigated the effects of the fatty acid-bile acid conjugate 3-arachidyl-amido , 7-12-dihydroxy , 5-cholan-24-oic acid ( Aramchol ; Trima Israel Pharmaceutical Products Ltd , Maabarot , Israel ) in a phase 2 trial of patients with nonalcoholic fatty liver disease ( NAFLD ) .